Supporting Quality and Patient Safety in Cancer Clinical Trials

Stephanie Badalucco

Kathleen Keane Reed

clinical trials, adverse event, adverse event management
CJON 2011, 15(3), 263-265. DOI: 10.1188/11.CJON.263-265

Adverse event (AE) reporting is a critical component of all cancer clinical trials, and the National Cancer Institute's Common Terminology Criteria for Adverse Events™ (CTCAE) is the primary system used by clinicians to describe the severity of AEs. The National Cancer Institute's Patient-Reported Outcomes version of the CTCAE (PRO-CTCAE) assesses patient self-reports of symptoms using a Web-based system that can be incorporated into all cancer clinical trials. Oncology clinical trial nurses are responsible for the protection and safety of patients enrolled in cancer trials and, therefore, should develop an understanding of PRO-CTCAE.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.